Skip to Main content Skip to Navigation
Conference papers

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Résumé : n.a
Document type :
Conference papers
Complete list of metadata

https://www.hal.inserm.fr/inserm-00663582
Contributor : Ed. Bmc Connect in order to contact the contributor
Submitted on : Friday, January 27, 2012 - 1:19:34 PM
Last modification on : Friday, December 3, 2021 - 12:13:07 PM
Long-term archiving on: : Saturday, April 28, 2012 - 2:26:33 AM

Files

Identifiers

Citation

Dominique Salmon-Céron, Christine Durier, Corinne Desaint, Lise Cuzin, Mathieu Surénaud, et al.. OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial. AIDS Vaccine 2009, Oct 2009, Paris, France. pp.O25, ⟨10.1186/1742-4690-6-S3-O25⟩. ⟨inserm-00663582⟩

Share

Metrics

Record views

718

Files downloads

1280